Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

2013185 citationsJournal Articlehybrid Open Access

Authors

Frank Buttgereit · Charité - Universitätsmedizin Berlin

Daksha Mehta · Altoona Arthritis and Osteoporosis Center

John Kirwan · University of Bristol

Jacek Szechiński

Maarten Boers · Amsterdam UMC Location VUmc

Rieke Alten · Charité - Universitätsmedizin Berlin

Jerzy Supronik · NZOZ Centrum Alergologii

Abstract

Low-dose MR prednisone added to existing DMARD treatment produced rapid and relevant improvements in RA signs and symptoms. CLINICALTRIALS.GOV, NUMBER: NCT00650078.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of the Rheumatic Diseases

Volume 72, Issue 2, pp. 204-210

DOI: 10.1136/annrheumdis-2011-201067

Field-Weighted Citation Impact: 18.14